Skip to main content
. Author manuscript; available in PMC: 2021 Jul 16.
Published in final edited form as: Clin Breast Cancer. 2019 Dec 5;20(3):220–227. doi: 10.1016/j.clbc.2019.11.010

Figure 2: Survival for patients stratified by the serum GP88 cut off of ≤55 and >55 ng/ml.

Figure 2:

Kaplan-Meier analysis of survival of MBC patients who were stratified into two groups based on their serum GP88 values. Hatched blue line (LL) corresponded to patients (74 patients) whose serum GP88 remained below or equal to 55 ng/ml. Solid red line (HH) corresponded to patients (17 patients) with serum GP88 levels remaining high > 55 ng/ml.